Literature DB >> 241610

Pneumococcal meningitis-therapeutic studies in mice.

Y H Tsai, E B Williams, R S Hirth, K E Price.   

Abstract

A technique for inducing pneumococcal meningitis in mice and a description of the histopathologic changes that accompany this experimentally produced disease are provided in the present report. This infection of mice was investigated to determine whether it could serve as a suitable model for detecting agents that have potential therapeutic utility in bacterial meningitis in man. 21 antibiotics, belonging to six major classes were evaluated for efficacy in the experimental infection. The three most active agents proved to be amoxicillin, cephaloridine, and chlortetracycline. Up to this time, amoxicillin has not been commercially available as an injectable dosage form. However, in view of the compound's outstanding efficacy in the present experiments, it would be desirable to investigate its effectiveness in the naturally occurring disease in man.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241610     DOI: 10.1159/000221879

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  8 in total

1.  Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.

Authors:  A Wellmer; J Gerber; J Ragheb; G Zysk; T Kunst; A Smirnov; W Brück; R Nau
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  Scope and limitations of experimental chemotherapy.

Authors:  O Zak
Journal:  Experientia       Date:  1980-04-15

3.  Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins.

Authors:  T Tang; P S Frenette; R O Hynes; D D Wagner; T N Mayadas
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

4.  Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.

Authors:  Y H Tsai; M Bies; F Leitner; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

5.  Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.

Authors:  U B Schaad; L M Grimm; G Beskid; R Cleeland; J D Nelson; G H McCracken
Journal:  Infection       Date:  1982       Impact factor: 3.553

6.  Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.

Authors:  N Klesel; M Limbert; E Schrinner; K Seeger; G Seibert; I Winkler
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

7.  In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.

Authors:  G Beskid; J G Christenson; R Cleeland; W DeLorenzo; P W Trown
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

8.  Method for inducing experimental pneumococcal meningitis in outbred mice.

Authors:  Damiana Chiavolini; Sergio Tripodi; Riccardo Parigi; Marco R Oggioni; Elisabetta Blasi; Marcella Cintorino; Gianni Pozzi; Susanna Ricci
Journal:  BMC Microbiol       Date:  2004-09-22       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.